全文获取类型
收费全文 | 1137667篇 |
免费 | 78027篇 |
国内免费 | 1868篇 |
专业分类
耳鼻咽喉 | 15158篇 |
儿科学 | 37770篇 |
妇产科学 | 29686篇 |
基础医学 | 178253篇 |
口腔科学 | 32611篇 |
临床医学 | 100370篇 |
内科学 | 213826篇 |
皮肤病学 | 26614篇 |
神经病学 | 81341篇 |
特种医学 | 41370篇 |
外国民族医学 | 136篇 |
外科学 | 169904篇 |
综合类 | 22402篇 |
现状与发展 | 2篇 |
一般理论 | 268篇 |
预防医学 | 84659篇 |
眼科学 | 26852篇 |
药学 | 87515篇 |
3篇 | |
中国医学 | 3196篇 |
肿瘤学 | 65626篇 |
出版年
2018年 | 11972篇 |
2017年 | 9107篇 |
2016年 | 10159篇 |
2015年 | 11259篇 |
2014年 | 15385篇 |
2013年 | 23532篇 |
2012年 | 31349篇 |
2011年 | 33423篇 |
2010年 | 19760篇 |
2009年 | 18553篇 |
2008年 | 31545篇 |
2007年 | 33814篇 |
2006年 | 34389篇 |
2005年 | 32424篇 |
2004年 | 31777篇 |
2003年 | 30187篇 |
2002年 | 29667篇 |
2001年 | 56396篇 |
2000年 | 57863篇 |
1999年 | 47657篇 |
1998年 | 12495篇 |
1997年 | 10688篇 |
1996年 | 11303篇 |
1995年 | 10585篇 |
1994年 | 9763篇 |
1993年 | 9137篇 |
1992年 | 36238篇 |
1991年 | 36389篇 |
1990年 | 35728篇 |
1989年 | 34995篇 |
1988年 | 31936篇 |
1987年 | 31332篇 |
1986年 | 29628篇 |
1985年 | 28086篇 |
1984年 | 20708篇 |
1983年 | 17627篇 |
1982年 | 9793篇 |
1979年 | 19430篇 |
1978年 | 13890篇 |
1977年 | 11727篇 |
1976年 | 11261篇 |
1975年 | 12605篇 |
1974年 | 14928篇 |
1973年 | 14220篇 |
1972年 | 13569篇 |
1971年 | 12862篇 |
1970年 | 12195篇 |
1969年 | 11389篇 |
1968年 | 10608篇 |
1967年 | 9513篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
We report a 51-year-old patient with severe haemophilia A developing a severe life-threatening anaphylactic reaction to recombinant factor VIII (rFVIII). Anaphylactic reactions are a rare but well-known side effect of FVIII products. The nature of these reactions could not be clarified as previous studies failed to demonstrate a specific IgE response. Here, we could prove a grade 3 anaphlyactic reaction as an IgE-mediated response to rFVIII for the first time by Western blotting. 相似文献
992.
993.
B Bonet M Viana I Sánchez-Vera A Quintanar J Martínez M Espino 《Diabetic medicine》2007,24(11):1192-1198
AIMS: The aims of our study were to determine if insulin resistance is associated with increased plasma levels of non-esterified fatty acids (NEFA), glycerol, 3-hydroxybutyrate and triglycerides in obese children. We also studied whether the presence of acanthosis nigricans (AN) led to further alterations in the above parameters. METHODS: A total of 101 children were studied on their first visit to the paediatric endocrine clinic. Seventy-four were obese, 30 of them with AN. The remaining 27 were non-obese healthy children (control group). NEFAs, glycerol, triglycerides, 3-hydroxybutyrate, insulin, leptin, adiponectin and glucose were determined in blood samples obtained after overnight fasting. The insulin resistance index (IRI) was calculated following the homeostasis model assessment (HOMA). Data from the three groups were compared using appropriate statistical tests. RESULTS: No differences in age, sex ratio and pubertal stage were observed among the three groups. The group of children with the highest body mass index (BMI) showed higher plasma levels of insulin and leptin, higher IRI and lower plasma levels of adiponectin. As insulin and IRI increased, NEFA and 3-hydroxybutyrate decreased and triglycerides increased. When obese children were categorized by BMI, the presence of AN further exacerbated these differences. CONCLUSIONS: In obese children, insulin resistance is associated with plasma lipid alterations suggestive of both decreased adipose tissue lipolysis and hepatic beta-oxidation and increased hepatic synthesis of triglycerides. Such a metabolic condition may facilitate fat storage and hinder weight loss. 相似文献
994.
995.
Urvashi Razdan R. M. Raizada V. N. Chaturvedi 《Indian journal of otolaryngology and head and neck surgery》2004,56(1):20-22
Objective To assess the efficacy of conservative modalities in the management of epistaxis.
Study design Prospective case studies.
Setting Rural medical college hospital.
Patients Indoor and outdoor patients with epistaxis.
lntervention Conservative(non surgical) management techniques in epistaxis.
Results Chemical cauterization was successful in 72.07% cases, anterior nasal packing in 84.5% and posterior nasal packing in 95.6%
cases.
Conclusion Out of 300 cases of epistaxis included in the study (except for one case that required internal maxillary artery ligation).
all cases were treated successfully with conservative treatment alongwith treating the underlying pathology causing epistaxis. 相似文献
996.
Anja S Lindman Marit B Veier?d Jan I Pedersen Aage Tverdal Inger Nj?lstad Randi Selmer 《European journal of cardiovascular prevention and rehabilitation》2007,14(4):501-507
AIMS: To evaluate the predictive accuracy of the Systematic Coronary Risk Evaluation (SCORE) project high-risk function in Norway. METHODS AND RESULTS: We included 57 229 individuals screened in 1985-1992 from two population-based surveys in Norway (age groups 40-49, 50-59, and 60-69 years). The data have been linked to the Norwegian Cause of Death Registry. The SCORE high-risk algorithm for the prediction of 10-year cardiovascular disease (CVD) mortality was applied, and the risk factors entered into the model were age, sex, total cholesterol, systolic blood pressure, and smoking (yes/no). The number of expected events estimated by the SCORE model (E) was compared with the observed numbers (O). The SCORE low-risk algorithm was studied for comparison. In men, the observed number of CVD deaths was 718, compared with 1464 estimated by the SCORE high-risk function (O/E ratios 0.53, 0.53 and 0.45, for age groups 40-49, 50-59 and 60-69, respectively). In women, the observed and expected numbers were 226 and 547. The O/E ratios decreased with age (ratios 0.60, 0.45 and 0.37, respectively), i.e. the overestimation increased with age. The low-risk function predicted reasonably well for men (ratios 0.85, 0.92 and 0.79, respectively), whereas an overestimation was found for women aged 50-59 and 60-69 years (ratios 0.69 and 0.56, respectively). CONCLUSION: The SCORE high-risk model overestimated the number of CVD deaths in Norway. Before implementation in clinical practice, proper adjustments to national levels are required. 相似文献
997.
Background It is estimated that skin cancers cost $33 million per annum to the New Zealand healthcare system. Basal cell carcinoma and squamous cell carcinoma are the commonest types of non melanoma skin cancers (NMSCs). Anecdotal evidence indicates that there has been a doubling in the incidence of NMSCs in New Zealand over the last decade. Because of the high incidence mandatory reporting of NMSCs to the National Cancer Registry is not required. This lack of accurate data has led to poor health care policies and strategies including funding and workforce planning. Aims The aims of this study are to (1) present the latest statistics on NMSCs in New Zealand, including the incidence across different regions over the last decade, patient demographics, anatomic distribution of NMSCs, incidence and sites of metastasis, and disease‐specific survival; to (2) the histopathology of NMSCs, including surgical margins, histologic grade, and perineural, lymphatic, and vascular invasion; and (3) the relative role of different faculties treating NMSCs. Method This project has been approved by the multi‐centre ethics committee. A retrospective review was conducted from patients’ histology records from public and private pathology laboratories within defined catchment areas. Criterion for analysis is a confirmed diagnosis of NMSC treated surgically. A Microsoft Access database is created that will facilitate subsequent data retrieval and analysis. Results and Conclusion It is hoped that this up‐to‐date data will form the framework for the development of sound and sustainable healthcare policies of management of NMSCs including management strategies and workforce planning, and research direction on this common disease. 相似文献
998.
M. Pickard E. P. Dewar R. C. Kapadia R. B. N. Khan I. F. Hutchinson A. Nejim 《Colorectal disease》2007,9(3):203-206
OBJECTIVE: The publication of the BSG guidelines in 2002 provided a framework for the follow up of patients with colorectal polyps. The aim of the present study was to determine whether they had, or were being correctly adhered to in a moderately sized District General Hospital. METHOD: A total of 598 patients were on the waiting list for colonoscopy at Airedale General Hospital (AGH) in February 2005. Of these, 203 were being followed up as a result of the previous finding of a polyp. RESULTS: Only 14.8% of patients had been or were being followed up according to the BSG guidelines. The majority of the 85.2% of patients who did not comply with follow up did so as a result of over investigation. Seventy-eight per cent of the low-risk group and 55% of the intermediate-risk group had been colonoscoped, or were waiting to have colonoscopy, too soon or too frequently according to the BSG guidelines. Twenty-four patients with hyperplastic polyps were being followed up incorrectly, as were 17 patients discovered to have a polyp pathology on flexible sigmoidoscopy. It was established that 131 extra colonoscopies had been, or were planned to be performed unnecessarily. CONCLUSION: These data have major implications with regard to patient safety, service provision and cost to the NHS. 相似文献
999.
1000.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献